Ouch, for Now. Progressive Care Does 200:1 Reverse.

MASSIVE REVERSE SPLIT Let's just watch from the sidelines for...

He Shoots And He Scores. Ardelyx (ARDX) Gains 78%. Happy New Year!

Ah yes, and Gains Come to the Patient, as the FDA Moves the Ardelyx Ball Further Along.
SILO Pharmaceutical, Psychedelic Stock Review

Silo Pharma (SILO) Announces Positive Study Results of SPU- 21 for Arthritis

SPU-21 effective in controlling arthritis progression. SPU-21 Demonstrates Positive Data in Arthritis Suppression using Silo’s Novel Joint Homing Peptide

Ardelyx (ARDX). Don’t be Nervous, It’s Just Money.

The Higher it Goes, The More Nervous we Get. LIVE QUOTE

FDA to Ardelyx: “Give us a Couple More Weeks.” (ARDX) $1.80.

Oh boy, another day, another snag. There goes our Christmas bonus, dang. LIVE QUOTE It's been...

Can Lightning Strike Twice? Mitesco (MITI, MITID) Health Clinics.

Mitesco one of our Past Clients, Gained 10-Fold After we Added it to the Watch List, Just did a Reverse Split...

Adding Unicycive (UNCY) $0.75 to the Watch List.

Similar to Ardlyx (ARDX) which we added to the Watch List last week, Unicycive (no we don't know how they pronounce it) which will call UNCY - is...

Adding Silo Pharma (SILO) $3.50 to Watch List.

Look What We Found! We launched the Psychedelic Stock Review a little more than a year ago and decided...

Silo Pharma (SILO) Issues Letter to Shareholders

Silo Pharma Issues Letter to Shareholders Detailing Progress on Pipeline Assets Combining Traditional Therapeutics with Psychedelic Medicine LIVE...

Provention Bio (PRVB) Gains 26% Last Week.

We're up 106% From Adding to the 2022 Watch List Last July. And up 26% a Week After Urging Holders to Calm...

Latest article

Society Pass (SOPA) $1.15 Breaks Above First Line of Resistance.

Just a Quick Heads Up. Price and Volume Gradually Picking up From Where we Added to Watch List on the 12th.

Silo Pharma (SILO) $2.67 Announces $1 Million Stock Buyback.

Yes it doesn't sound like a lot of money on the surface. But the stock is so grossly undervalued (in our opinion)...

Three That Doubled, Three More That May Double.

Ardelyx $3.00 (ARDX) Gains 117%, Provention Bio $8.75 (PRVB) Gains 134%, and PharmaTher (PHRRF) up 154%. Blue Skies Ahead - For All...